Critical Analysis: Ethema Health (OTCMKTS:GRST) versus Bausch + Lomb (NYSE:BLCO)

Bausch + Lomb (NYSE:BLCO) and Ethema Health (OTCMKTS:GRST) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.

Institutional and Insider Ownership

11.1% of Bausch + Lomb shares are held by institutional investors. 1.5% of Bausch + Lomb shares are held by insiders. Comparatively, 55.8% of Ethema Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Bausch + Lomb and Ethema Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bausch + Lomb	-4.21%	3.60%	1.69%
Ethema Health	-9.35%	N/A	-5.77%

Risk and Volatility

Bausch + Lomb has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500. Comparatively, Ethema Health has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and target prices for Bausch + Lomb and Ethema Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch + Lomb	1	9	4	0	2.21
Ethema Health	0	0	0	0	0.00

Bausch + Lomb currently has a consensus price target of $18.08, indicating a potential upside of 14.90%. Given Bausch + Lomb’s stronger consensus rating and higher probable upside, research analysts plainly believe Bausch + Lomb is more favorable than Ethema Health.

Earnings and Valuation

This table compares Bausch + Lomb and Ethema Health”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch + Lomb	$5.10 billion	1.10	-$360.00 million	($0.62)	-25.39
Ethema Health	$6.02 million	0.00	-$2.06 million	N/A	N/A

Ethema Health has lower revenue, but higher earnings than Bausch + Lomb.

Summary

Bausch + Lomb beats Ethema Health on 8 of the 11 factors compared between the two stocks.

About Bausch + Lomb

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.

About Ethema Health

Ethema Health Corporation operates behavioral healthcare space specifically in the treatment of substance use disorders. It offers rehabilitation services. The company was formerly known as GreeneStone Healthcare Corporation and changed its name to Ethema Health Corporation in April 2017. Ethema Health Corporation is based in West Palm Beach, Florida.